These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24926467)

  • 1. Altered histone modifications in gliomas.
    Kim YZ
    Brain Tumor Res Treat; 2014 Apr; 2(1):7-21. PubMed ID: 24926467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic Events.
    Martínez R
    J Signal Transduct; 2012; 2012():519807. PubMed ID: 22778947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic aberrations in malignant gliomas: an open door leading to better understanding and treatment.
    Martinez R; Schackert G
    Epigenetics; 2007; 2(3):147-50. PubMed ID: 18063907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting post-translational histone modifying enzymes in glioblastoma.
    Kunadis E; Lakiotaki E; Korkolopoulou P; Piperi C
    Pharmacol Ther; 2021 Apr; 220():107721. PubMed ID: 33144118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
    Was H; Krol SK; Rotili D; Mai A; Wojtas B; Kaminska B; Maleszewska M
    Clin Epigenetics; 2019 Jan; 11(1):11. PubMed ID: 30654849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma epigenetics: From subclassification to novel treatment options.
    Gusyatiner O; Hegi ME
    Semin Cancer Biol; 2018 Aug; 51():50-58. PubMed ID: 29170066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SENP1-mediated SUMOylation of SIRT1 affects glioma development through the NF-κB pathway.
    Liu X; Zhang S; Dong Y; Xie Y; Li Q
    Exp Cell Res; 2023 Dec; 433(2):113822. PubMed ID: 37866458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the epigenetics of glioblastomas.
    Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N
    Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic changes in gliomas.
    Burgess R; Jenkins R; Zhang Z
    Cancer Biol Ther; 2008 Sep; 7(9):1326-34. PubMed ID: 18836290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics in human gliomas.
    Kreth S; Thon N; Kreth FW
    Cancer Lett; 2014 Jan; 342(2):185-92. PubMed ID: 22531315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global DNA Methylation Patterns in Human Gliomas and Their Interplay with Other Epigenetic Modifications.
    J Dabrowski M; Wojtas B
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA methylome of glioblastoma multiforme.
    Martinez R; Esteller M
    Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas.
    Erfani P; Tome-Garcia J; Canoll P; Doetsch F; Tsankova NM
    Epigenetics; 2015; 10(6):496-507. PubMed ID: 25996283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of methylation and acetylation of high
    Zhang L; Wang D; Han X; Tang F; Gao D
    Heliyon; 2019 Jun; 5(6):e01951. PubMed ID: 31294105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Epigenetics and Oxidative Stress in Gliomagenesis.
    Sanchez-Perez Y; Soto-Reyes E; Garcia-Cuellar CM; Cacho-Diaz B; Santamaria A; Rangel-Lopez E
    CNS Neurol Disord Drug Targets; 2017; 16(10):1090-1098. PubMed ID: 29318979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia.
    Janczar S; Janczar K; Pastorczak A; Harb H; Paige AJ; Zalewska-Szewczyk B; Danilewicz M; Mlynarski W
    Cancers (Basel); 2017 Jan; 9(1):. PubMed ID: 28054944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation in cancer progression.
    Baxter E; Windloch K; Gannon F; Lee JS
    Cell Biosci; 2014; 4():45. PubMed ID: 25949794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated chromatin remodeling in the pathobiology of brain tumors.
    Spyropoulou A; Piperi C; Adamopoulos C; Papavassiliou AG
    Neuromolecular Med; 2013 Mar; 15(1):1-24. PubMed ID: 23114751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.